Prometheus Biosciences - Ownership and Business Overview

Life ScienceCompany

Prometheus Biosciences Ownership

Who owns Prometheus Biosciences?

Prometheus Biosciences is owned by Merck. It was acquired on April 16, 2023.

Prometheus Biosciences Business Overview

Where is Prometheus Biosciences headquartered?

Prometheus Biosciences is headquartered in San Diego, California.

What is Prometheus Biosciences’ revenue?

Prometheus Biosciences disclosed revenue of 6M USD for 2022 and 3M USD for 2021.

How many employees does Prometheus Biosciences have?

Prometheus Biosciences has 72 employees.

What sector is Prometheus Biosciences in?

Prometheus Biosciences is a life science company.

When was Prometheus Biosciences founded?

Prometheus Biosciences was founded in 2016.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 192 acquisitions of life science companies in 2023, including 19 acquisitions by private equity firms, and 173 by strategics.

Prometheus Biosciences

Prometheus Biosciences, Inc.

9410 Carroll Park Drive,
San Diego, California 92121
United States,
(858) 684-1300
www.prometheusbiosciences.com

Prometheus Biosciences is a clinical-stage biotechnology company provides medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. Prometheus Biosciences was founded in 2016 and is based in San Diego, California.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.